A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Summary

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Moderate to Severe Chronic Obstructive Pulmonary Disease

Eligibility basics and study details

Study type

Interventional

Phase

Phase 2/3

Ages

35 to 80 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

Pfizer

Last updated on ClinicalTrials.gov

August 31, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites